Literature DB >> 3977601

Accidental exposure to sarin: vision effects.

R H Rengstorff.   

Abstract

Two men were accidentally exposed to vapors of sarin, a cholinesterase inhibitor and extremely toxic nerve gas. Diagnosis was confirmed by depressed cholinesterase activity, and fixed extremely miotic pupils. No other signs or symptoms developed and neither man required treatment. Recovery to normal cholinesterase activity was gradual over a 90-day period. Pupillary reflexes were not detectable until 11 days after exposure; the miotic pupils dilated slowly over a 30-45 day-period. Eye pain and blurred vision did not occur; visual acuity and amplitude of accommodation were improved for several weeks. Other functions not affected significantly were intraocular pressure, visual fields, color vision, heterophorias, and vergences.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3977601     DOI: 10.1007/bf00333427

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  7 in total

1.  Miotic drugs: a review of ocular, visual, and systemic complications.

Authors:  R Rengstorff; M Royston
Journal:  Am J Optom Physiol Opt       Date:  1976-02

2.  Interconversion of cholinesterase enzyme activity units by the manual delta pH method and a recommended automated method.

Authors:  W A Groff; A Kaminskis; R I Ellin
Journal:  Clin Toxicol       Date:  1976       Impact factor: 4.467

3.  A comparative study of central visual field changes induced by sarin vapour and physostigmine eye drops.

Authors:  M F Gazzard; D P Thomas
Journal:  Exp Eye Res       Date:  1975-01       Impact factor: 3.467

4.  The effect of locally applied cholinesterase inhibitors and oximes on the acetylcholinesterase activity in different parts of the guinea-pig eye.

Authors:  R Lund-Karlsen; F Fonnum
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1976-04

5.  Soman and sarin: clinical manifestations and treatment of accidental poisoning by organophosphates.

Authors:  F R Sidell
Journal:  Clin Toxicol       Date:  1974       Impact factor: 4.467

6.  Myopia induced by ocular instillation of physostigmine.

Authors:  R H Rengstorff
Journal:  Am J Optom Arch Am Acad Optom       Date:  1970-03

7.  Cyclopentolate in treatment of sarin miosis.

Authors:  R J Moylan-Jones; D P Thomas
Journal:  Br J Pharmacol       Date:  1973-06       Impact factor: 8.739

  7 in total
  7 in total

1.  Sarin poisoning of a rescue team in the Matsumoto sarin incident in Japan.

Authors:  T Nakajima; S Sato; H Morita; N Yanagisawa
Journal:  Occup Environ Med       Date:  1997-10       Impact factor: 4.402

2.  Audiological assessment in organophosphorus compound poisoning.

Authors:  V Ashok Murthy; Y J Visweswara Reddy
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-03-21

Review 3.  Sarin (GB, O-isopropyl methylphosphonofluoridate) neurotoxicity: critical review.

Authors:  Mohamed B Abou-Donia; Briana Siracuse; Natasha Gupta; Ashly Sobel Sokol
Journal:  Crit Rev Toxicol       Date:  2016-10-05       Impact factor: 5.635

4.  Efficacy assessment of a combined anticholinergic and oxime treatment against topical sarin-induced miosis and visual impairment in rats.

Authors:  A Gore; E Bloch-Shilderman; I Egoz; J Turetz; R Brandeis
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

5.  Effects of sarin on the nervous system in rescue team staff members and police officers 3 years after the Tokyo subway sarin attack.

Authors:  Y Nishiwaki; K Maekawa; Y Ogawa; N Asukai; M Minami; K Omae
Journal:  Environ Health Perspect       Date:  2001-11       Impact factor: 9.031

6.  Advances in toxicology and medical treatment of chemical warfare nerve agents.

Authors:  Mohammd Moshiri; Emadodin Darchini-Maragheh; Mahdi Balali-Mood
Journal:  Daru       Date:  2012-11-28       Impact factor: 3.117

Review 7.  Toxicity of the organophosphate chemical warfare agents GA, GB, and VX: implications for public protection.

Authors:  N Munro
Journal:  Environ Health Perspect       Date:  1994-01       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.